Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application

U. Baccarani, A. Sanna, A. Cariani, M. Sainz, G. L. Adani, D. Lorenzin, D. Montanaro, M. Scalamogna, G. Piccolo, A. Risaliti, F. Bresadola, A. Donini

Research output: Contribution to journalArticle

Abstract

We Aimed to analyze the in vitro function of isolated and cryopreserved human hepatocytes (CHH) from a cell bank and to define their potential clinical application in a bioartificial liver (BAL) device. Methods. Over 24 months, 103 not transplantable livers were utilized for human hepatocytes isolation and cryopreservation. Hepatocytes isolated by collagenase were analyzed for yield, viability, diazepam metabolism, and production of human albumin after isolation and cryopreservation in LN2. Results. The causes for refusal for transplantation were macrosteatosis >60%, ischemic damage due to donor hypotension, and nonviral cirrhosis in 60%, 11%, and 8%, respectively. Cell yields averaged 7 million hepatocytes per gram of liver of mean viability of 80% ± 13%. The viability of CHH after thawing averaged 50%. Thawed hepatocytes showed diazepam metabolism, and human albumin synthesis comparable to fresh cells. CHH were utilized as the biological component of a BAL for temporary support as three applications of two patients affected by fulminant hepatic failure awaiting urgent transplant. Ten to 13 billion viable CHH were loaded into each BAL. Liver function showed bilirubin and ammonia reduction at the end of each treatment. One patient was successfully bridged to emergency OLTx after one BAL; in the second case there was spontaneous recovery of liver function after two BAL. Conclusions. Recovery of donor human livers unwanted for transplantation allowed isolation and cryopreservation of viable and functionally active human hepatocytes, which have been banked and successfully used for clinical applications of a BAL device.

Original languageEnglish
Pages (from-to)256-259
Number of pages4
JournalTransplantation Proceedings
Volume37
Issue number1
DOIs
Publication statusPublished - Jan 2005

Fingerprint

Artificial Liver
Hepatocytes
Cryopreservation
Liver
Diazepam
Albumins
Tissue Donors
In Vitro Techniques
Equipment and Supplies
Acute Liver Failure
Recovery of Function
Collagenases
Bilirubin
Ammonia
Liver Transplantation
Hypotension
Emergencies
Fibrosis
Transplantation
Transplants

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Baccarani, U., Sanna, A., Cariani, A., Sainz, M., Adani, G. L., Lorenzin, D., ... Donini, A. (2005). Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application. Transplantation Proceedings, 37(1), 256-259. https://doi.org/10.1016/j.transproceed.2004.12.230

Cryopreserved human hepatocytes from cell bank : In vitro function and clinical application. / Baccarani, U.; Sanna, A.; Cariani, A.; Sainz, M.; Adani, G. L.; Lorenzin, D.; Montanaro, D.; Scalamogna, M.; Piccolo, G.; Risaliti, A.; Bresadola, F.; Donini, A.

In: Transplantation Proceedings, Vol. 37, No. 1, 01.2005, p. 256-259.

Research output: Contribution to journalArticle

Baccarani, U, Sanna, A, Cariani, A, Sainz, M, Adani, GL, Lorenzin, D, Montanaro, D, Scalamogna, M, Piccolo, G, Risaliti, A, Bresadola, F & Donini, A 2005, 'Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application', Transplantation Proceedings, vol. 37, no. 1, pp. 256-259. https://doi.org/10.1016/j.transproceed.2004.12.230
Baccarani, U. ; Sanna, A. ; Cariani, A. ; Sainz, M. ; Adani, G. L. ; Lorenzin, D. ; Montanaro, D. ; Scalamogna, M. ; Piccolo, G. ; Risaliti, A. ; Bresadola, F. ; Donini, A. / Cryopreserved human hepatocytes from cell bank : In vitro function and clinical application. In: Transplantation Proceedings. 2005 ; Vol. 37, No. 1. pp. 256-259.
@article{fdac8a23f4434633b7233a181f674320,
title = "Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application",
abstract = "We Aimed to analyze the in vitro function of isolated and cryopreserved human hepatocytes (CHH) from a cell bank and to define their potential clinical application in a bioartificial liver (BAL) device. Methods. Over 24 months, 103 not transplantable livers were utilized for human hepatocytes isolation and cryopreservation. Hepatocytes isolated by collagenase were analyzed for yield, viability, diazepam metabolism, and production of human albumin after isolation and cryopreservation in LN2. Results. The causes for refusal for transplantation were macrosteatosis >60{\%}, ischemic damage due to donor hypotension, and nonviral cirrhosis in 60{\%}, 11{\%}, and 8{\%}, respectively. Cell yields averaged 7 million hepatocytes per gram of liver of mean viability of 80{\%} ± 13{\%}. The viability of CHH after thawing averaged 50{\%}. Thawed hepatocytes showed diazepam metabolism, and human albumin synthesis comparable to fresh cells. CHH were utilized as the biological component of a BAL for temporary support as three applications of two patients affected by fulminant hepatic failure awaiting urgent transplant. Ten to 13 billion viable CHH were loaded into each BAL. Liver function showed bilirubin and ammonia reduction at the end of each treatment. One patient was successfully bridged to emergency OLTx after one BAL; in the second case there was spontaneous recovery of liver function after two BAL. Conclusions. Recovery of donor human livers unwanted for transplantation allowed isolation and cryopreservation of viable and functionally active human hepatocytes, which have been banked and successfully used for clinical applications of a BAL device.",
author = "U. Baccarani and A. Sanna and A. Cariani and M. Sainz and Adani, {G. L.} and D. Lorenzin and D. Montanaro and M. Scalamogna and G. Piccolo and A. Risaliti and F. Bresadola and A. Donini",
year = "2005",
month = "1",
doi = "10.1016/j.transproceed.2004.12.230",
language = "English",
volume = "37",
pages = "256--259",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Cryopreserved human hepatocytes from cell bank

T2 - In vitro function and clinical application

AU - Baccarani, U.

AU - Sanna, A.

AU - Cariani, A.

AU - Sainz, M.

AU - Adani, G. L.

AU - Lorenzin, D.

AU - Montanaro, D.

AU - Scalamogna, M.

AU - Piccolo, G.

AU - Risaliti, A.

AU - Bresadola, F.

AU - Donini, A.

PY - 2005/1

Y1 - 2005/1

N2 - We Aimed to analyze the in vitro function of isolated and cryopreserved human hepatocytes (CHH) from a cell bank and to define their potential clinical application in a bioartificial liver (BAL) device. Methods. Over 24 months, 103 not transplantable livers were utilized for human hepatocytes isolation and cryopreservation. Hepatocytes isolated by collagenase were analyzed for yield, viability, diazepam metabolism, and production of human albumin after isolation and cryopreservation in LN2. Results. The causes for refusal for transplantation were macrosteatosis >60%, ischemic damage due to donor hypotension, and nonviral cirrhosis in 60%, 11%, and 8%, respectively. Cell yields averaged 7 million hepatocytes per gram of liver of mean viability of 80% ± 13%. The viability of CHH after thawing averaged 50%. Thawed hepatocytes showed diazepam metabolism, and human albumin synthesis comparable to fresh cells. CHH were utilized as the biological component of a BAL for temporary support as three applications of two patients affected by fulminant hepatic failure awaiting urgent transplant. Ten to 13 billion viable CHH were loaded into each BAL. Liver function showed bilirubin and ammonia reduction at the end of each treatment. One patient was successfully bridged to emergency OLTx after one BAL; in the second case there was spontaneous recovery of liver function after two BAL. Conclusions. Recovery of donor human livers unwanted for transplantation allowed isolation and cryopreservation of viable and functionally active human hepatocytes, which have been banked and successfully used for clinical applications of a BAL device.

AB - We Aimed to analyze the in vitro function of isolated and cryopreserved human hepatocytes (CHH) from a cell bank and to define their potential clinical application in a bioartificial liver (BAL) device. Methods. Over 24 months, 103 not transplantable livers were utilized for human hepatocytes isolation and cryopreservation. Hepatocytes isolated by collagenase were analyzed for yield, viability, diazepam metabolism, and production of human albumin after isolation and cryopreservation in LN2. Results. The causes for refusal for transplantation were macrosteatosis >60%, ischemic damage due to donor hypotension, and nonviral cirrhosis in 60%, 11%, and 8%, respectively. Cell yields averaged 7 million hepatocytes per gram of liver of mean viability of 80% ± 13%. The viability of CHH after thawing averaged 50%. Thawed hepatocytes showed diazepam metabolism, and human albumin synthesis comparable to fresh cells. CHH were utilized as the biological component of a BAL for temporary support as three applications of two patients affected by fulminant hepatic failure awaiting urgent transplant. Ten to 13 billion viable CHH were loaded into each BAL. Liver function showed bilirubin and ammonia reduction at the end of each treatment. One patient was successfully bridged to emergency OLTx after one BAL; in the second case there was spontaneous recovery of liver function after two BAL. Conclusions. Recovery of donor human livers unwanted for transplantation allowed isolation and cryopreservation of viable and functionally active human hepatocytes, which have been banked and successfully used for clinical applications of a BAL device.

UR - http://www.scopus.com/inward/record.url?scp=20144388347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144388347&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2004.12.230

DO - 10.1016/j.transproceed.2004.12.230

M3 - Article

C2 - 15808612

AN - SCOPUS:20144388347

VL - 37

SP - 256

EP - 259

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 1

ER -